Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial
par Bleiberg, Harry 
;Gerard, Béatrice;Dalesio, Otilia;Crespeigne, Nadine;Rozencweig, Marcel
Référence Cancer chemotherapy and pharmacology, 22, 4, page (316-320)
Publication Publié, 1988
;Gerard, Béatrice;Dalesio, Otilia;Crespeigne, Nadine;Rozencweig, Marcel Référence Cancer chemotherapy and pharmacology, 22, 4, page (316-320)
Publication Publié, 1988
Article révisé par les pairs
| Titre: |
|
| Auteur: | Bleiberg, Harry; Gerard, Béatrice; Dalesio, Otilia; Crespeigne, Nadine; Rozencweig, Marcel |
| Informations sur la publication: | Cancer chemotherapy and pharmacology, 22, 4, page (316-320) |
| Statut de publication: | Publié, 1988 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Adolescent |
| Adult | |
| Aged | |
| Antiemetics -- therapeutic use | |
| Clinical Trials as Topic | |
| Dexamethasone -- therapeutic use | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Pyrrolidines -- therapeutic use | |
| Random Allocation | |
| Note générale: | SCOPUS: ar.j |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0344-5704 |
| info:doi/10.1007/BF00254238 | |
| info:scp/0023690593 | |
| info:pmid/3048762 | |
| VX-004202 |
